journal article·2025-01Open access

Tailored polysaccharide entrapping metal-organic framework for RNAi therapeutics and diagnostics in atherosclerosis

Sen Li, Han Gao, Haoji Wang, Xiaolin Zhao, Da Pan, Idaira Pacheco-Fernández, Ming Ma, Jianjun Liu, Jouni Hirvonen, Zehua Liu, Hélder A. Santos

Abstract

Metal-organic frameworks (MOFs) hold promise as theranostic carriers for atherosclerosis. However, to further advance their therapeutic effects with higher complexity and functionality, integrating multiple components with complex synthesis procedures are usually involved. Here, we reported a facile and general strategy to prepare multifunctional anti-atherosclerosis theranostic platform in a single-step manner. A custom-designed multifunctional polymer, poly(butyl methacrylate-co-methacrylic acid) branched phosphorylated β-glucan (PBMMA-PG), can effectively entrap different MOFs via coordination, simultaneously endow the MOF with enhanced stability, lesional macrophages selectivity and enhanced endosome escape. Sequential ex situ characterization and computational studies elaborated the potential mechanism. This facile post-synthetic modification granted the administered nanoparticles atherosclerotic tropism by targeting Dectin-1 + macrophages, enhancing in situ MR signal intensity by 72 %. Delivery of siNLRP3 effectively mitigated NLRP3 inflammasomes activation, resulting a 43 % reduction of plaque area. Overall, the current study highlights a simple and general approach for fabricating a MOF-based theranostic platform towards atherosclerosis conditioning, which may also expand to other indications targeting the lesional macrophages. • Tailored coordination on metal-organic frameworks (MOFs) with polysaccharide phosphate. • Rational design of multifunctional polysaccharide for MOFs entrapment, intracellular delivery and macrophage targeting. • Investigation on the small interfering RNA (siRNA) delivery potential of Iron(III)-based MOFs with diverse topologies. • A simple, yet versatile “MOF-in-net” strategy is presented. • The developed “all-in-one” nanosystem shows superior therapeutic efficacy and diagnostics in atherosclerosis conditioning.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: MicroRNA in disease regulation · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (78)

Show source-provided references
1. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?10.1038/s41569-021-00668-4 ↗
2. Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis10.1038/s44161-023-00354-3 ↗
3. Macrophages in the pathogenesis of atherosclerosis10.1016/j.cell.2011.04.005 ↗
4. Inflammation and plaque vulnerability10.1111/joim.12406 ↗
5. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques10.1161/01.RES.0000260802.75766.00 ↗
6. Cholesterol, inflammation and innate immunity10.1038/nri3793 ↗
7. Non-viral nanoparticles for RNA interference: principles of design and practical guidelines
8. Targeting inflammation in atherosclerosis — from experimental insights to the clinic10.1038/s41573-021-00198-1 ↗
9. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis10.1038/s41569-021-00629-x ↗
10. In depth analysis of the in vivo toxicity of nanoparticles of porous iron(iii) metal–organic frameworks10.1039/c3sc22116d ↗
11. Iron-based metal-organic framework: synthesis, structure and current technologies for water reclamation with deep insight into framework integrity10.1016/j.chemosphere.2021.131171 ↗
12. Application and development prospect of nanoscale iron based metal-organic frameworks in biomedicine10.2147/IJN.S417543 ↗
13. Research progress in iron-based nanozymes: catalytic mechanisms, classification, and biomedical applications10.1021/acs.analchem.3c01005 ↗
14. Dynamic effects of endo–exogenous stimulations on enzyme-activatable polymeric nanosystems with photo–sono–chemo synergy10.1021/acsami.2c05276 ↗
15. Tumor-anchoring drug-loaded fibrous microspheres for MR imaging-guided local chemotherapy and metastasis inhibition10.1007/s42765-022-00137-8 ↗
16. Temperature-regulating phase change fiber scaffold toward mild photothermal–chemotherapy10.1007/s42765-022-00199-8 ↗
17. NIR-II-Triggered composite nanofibers to simultaneously achieve intracranial hemostasis, killing superbug and residual cancer cells in brain tumor resection surgery10.1007/s42765-022-00210-2 ↗
18. Rational design of metal-organic frameworks to deliver methotrexate for targeted rheumatoid arthritis therapy10.1016/j.jconrel.2020.10.069 ↗
19. Metal–organic frameworks meet polymers: from synthesis strategies to healthcare applications10.1002/adma.202300700 ↗
20. MOF/polymer hybrids through in situ free radical polymerization in metal-organic frameworks10.1039/D2MH01202B ↗
21. Versatile surface functionalization of metal–organic frameworks through direct metal coordination with a phenolic lipid enables diverse applications10.1002/adfm.201705274 ↗
22. Metal–organic frameworks embedded in a liposome facilitate overall photocatalytic water splitting10.1038/s41557-020-00635-5 ↗
23. A pH-responsive cluster metal–organic framework nanoparticle for enhanced tumor accumulation and antitumor effect
24. Multifunctional metal-organic framework-based nanoreactor for starvation/oxidation improved indoleamine 2,3-dioxygenase-blockade tumor immunotherapy10.1038/s41467-022-30436-y ↗
25. Cyclodextrin metal–organic frameworks and derivatives: recent developments and applications10.1039/D1CS00550B ↗
26. Versatile amorphous structures of phosphonate Metal−Organic framework/alginate composite for tunable sieving of ions10.1002/adfm.201904016 ↗
27. Transition-metal coordinate bonds for bioinspired macromolecules with tunable mechanical properties10.1038/s41578-020-00270-z ↗
28. Formulation of metal–organic framework-based drug carriers by controlled coordination of methoxy PEG phosphate: boosting colloidal stability and redispersibility10.1021/jacs.1c03943 ↗
29. Metal-organic frameworks for gene therapy and detection
30. General and direct method for preparing oligonucleotide-functionalized metal–organic framework nanoparticles10.1021/jacs.7b05633 ↗
31. Direct synthesis of amorphous coordination polymers and metal–organic frameworks10.1038/s41570-023-00474-1 ↗
32. Polarity control of DNA adsorption enabling the surface functionalization of CuO nanozymes for targeted tumor therapy10.1039/D0MH01372B ↗
33. Dectin-1 deficiency does not affect atherosclerosis development in mice10.1016/j.atherosclerosis.2015.02.005 ↗
34. Fabrication of easy separable and reusable MIL-125(Ti)/MIL-53(Fe) binary MOF/CNT/Alginate composite microbeads for tetracycline removal from water bodies10.1038/s41598-021-03428-z ↗
35. Metal-organic framework (MIL-100 (Fe)): synthesis, detailed photocatalytic dye degradation ability in colored textile wastewater and recycling10.1016/j.materresbull.2017.12.033 ↗
36. Promoting cardiac repair through simple engineering of nanoparticles with exclusive targeting capability toward myocardial reperfusion injury by thermal resistant microfluidic platform
37. End group removal and modification of RAFT polymers10.1039/B9PY00340A ↗
38. T. Lu, Sobtop, 1.0(dev3.2), in.
39. Open Babel: an open chemical toolbox10.1186/1758-2946-3-33 ↗
40. Metal–organic framework nanocarriers for drug delivery in biomedical applications10.1007/s40820-020-00423-3 ↗
41. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation10.1038/s41586-018-0761-3 ↗
42. Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications10.1039/D1CS00918D ↗
43. Role of MIL-53(Fe)/hydrated–dehydrated MOF catalyst for electrochemical hydrogen evolution reaction (HER) in alkaline medium and photocatalysis10.1039/C8RA08208A ↗
44. Metal–organic framework nanoparticles
45. A cage-on-MOF strategy to coordinatively functionalize mesoporous MOFs for manipulating selectivity in adsorption and catalysis10.1038/s41467-023-40973-9 ↗
46. Alginate di-aldehyde-modified metal-organic framework nanocarriers as delivery platform and adjuvant in inactivated pseudorabies vaccination10.1039/D3MH02251J ↗
47. Dectin-1 deficiency does not affect atherosclerosis development in mice10.1016/j.atherosclerosis.2015.02.005 ↗
48. Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues10.1016/j.jconrel.2023.03.037 ↗
49. Phosphate and phytate adsorption and precipitation on ferrihydrite surfaces
50. Frisch · Gaussian 16 Rev. A. · 2016 · 1
51. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density10.1103/PhysRevB.37.785 ↗
52. Consequences of triplet aromaticity in 4nπ-electron annulenes: calculation of magnetic shieldings for open-shell species10.1002/(SICI)1521-3773(19980803)37:13/14<1945::AID-ANIE1945>3.0.CO;2-E ↗
53. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
54. A virus‐mimicking pH‐responsive acetalated dextran‐based membrane‐active polymeric nanoparticle for intracellular delivery of antitumor therapeutics
55. GROMACS: fast, flexible, and free10.1002/jcc.20291 ↗
56. Molecular dynamics simulation study of water surfaces: comparison of flexible water models10.1021/jp1067022 ↗
57. Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity10.1002/eji.201646849 ↗
58. Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'10.1038/nature10071 ↗
59. siRNAs: applications in functional genomics and potential as therapeutics10.1038/nrd1345 ↗
60. Metal–organic framework MIL-53(Fe): facile microwave-assisted synthesis and use as a highly active peroxidase mimetic for glucose biosensing10.1039/C4RA15840G ↗
61. Identification of ROS using oxidized DCFDA and flow-cytometry10.1007/978-1-60761-411-1_4 ↗
62. Antiinflammatory therapy with canakinumab for atherosclerotic disease10.1056/NEJMoa1707914 ↗
63. Efficacy and safety of low-dose colchicine after myocardial infarction10.1056/NEJMoa1912388 ↗
64. NLRP3 inflammasome activation in THP-1 target cells triggered by pathogenic naegleria fowleri10.1128/IAI.00275-16 ↗
65. Animal models of atherosclerosis–supportive notes and tricks of the trade10.1161/CIRCRESAHA.122.320263 ↗
66. Diet and murine atherosclerosis10.1161/01.ATV.0000201071.49029.17 ↗
67. Reactive oxygen species generation and atherosclerosis10.1161/ATVBAHA.117.309228 ↗
68. Magnetic resonance imaging of atherosclerotic plaque at clinically relevant field strengths (1T) by targeting the integrin α4β110.1038/s41598-018-21893-x ↗
69. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression10.1016/j.jcmg.2012.06.016 ↗
70. Concept of vulnerable/unstable plaque10.1161/ATVBAHA.108.179739 ↗
71. Western diet triggers NLRP3-dependent innate immune reprogramming10.1016/j.cell.2017.12.013 ↗
72. Strategies, design, and chemistry in siRNA delivery systems10.1016/j.addr.2019.05.004 ↗
73. siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice10.1126/scitranslmed.aay1063 ↗
74. Multifunctional nanohybrid based on porous silicon nanoparticles, gold nanoparticles, and acetalated dextran for liver regeneration and acute liver failure theranostics
75. Autologous skin fibroblast-based PLGA nanoparticles for treating multiorgan fibrosis10.1002/advs.202200856 ↗
76. PET/MR imaging of inflammation in atherosclerosis10.1038/s41551-022-00970-7 ↗
77. Metal-organic-frameworks as contrast agents in magnetic resonance imaging10.1002/cben.201600027 ↗
78. Trained immunity in atherosclerotic cardiovascular disease10.1161/ATVBAHA.120.314216 ↗